Literature DB >> 2202313

Statistical approaches to classification. Methods for developing classification and other criteria rules.

D A Bloch1, L E Moses, B A Michel.   

Abstract

Mesh：

Year:  1990        PMID： 2202313     DOI： 10.1002/art.1780330813

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  6 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  A brief history of medical taxonomy and diagnosis.

Authors:  Geza P Balint; W Watson Buchanan; Jan Dequeker
Journal:  Clin Rheumatol       Date:  2006-02-02       Impact factor: 2.980

3.  Influence of corticosteroid treatment on MRI findings in giant cell arteritis.

Authors:  T A Bley; T Ness; K Warnatz; A Frydrychowicz; M Uhl; J Hennig; M Langer; M Markl
Journal:  Clin Rheumatol       Date:  2006-10-05       Impact factor: 2.980

4.  Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out.

Authors:  Saralynn Allaire; Frederick Wolfe; Jingbo Niu; Yuqing Zhang; Bin Zhang; Michael LaValley
Journal:  Arthritis Rheum       Date:  2008-08-15

5.  Current risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohort.

Authors:  Saralynn Allaire; Frederick Wolfe; Jingbo Niu; Michael P LaValley; Bin Zhang; Susan Reisine
Journal:  Arthritis Rheum       Date:  2009-03-15

Review 6.  Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Authors:  V Boom; J Anton; P Lahdenne; P Quartier; A Ravelli; N M Wulffraat; S J Vastert
Journal:  Pediatr Rheumatol Online J       Date:  2015-12-03       Impact factor: 3.054
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.